Carbohydrate Mouth Rinse (Small-Sided Soccer Games) (CHOMR-SSGs)

May 19, 2025 updated by: Ersan Arslan, Tokat Gaziosmanpasa University

Carbohydrate Mouth Rinse Reduces Perceived Exertion and Mental Fatigue, and Improves Technical Actions During Small-Sided Soccer Games

The present study evaluated the influence of carbohydrate mouth-rinsing (CHO- MR) and placebo (PLA) conditions on the psychophysiological responses, kinematic profiles, and technical performance of young male soccer players in 4-Small sided games (SSGs). The study participants were involved in a randomized, double-blind, repeated-measures design that employed 3 sessions (familiarization, CHOMR and PLA) over fifteen days at a testing facility. Participants took part in two test sessions one week apart. CHO solution was a maltodextrin-based mixture containing 6.4% maltodextrin (Protein Ocean, Türkiye). The PLA solution consisted of pure water. Both solutions were made indistinguishable by incorporating 50 mg of a non-calorific artificial sweetener and 50 mg og sucralose (Fibrelle, Türkiye). A 25-ml bolus of 6.4% maltodextrin solution was utilized in a pre-weighed plastic cup, with sucralose water tested as PLA for each rinse solution.

Study Overview

Detailed Description

The current study used a double-blind, randomized, and counterbalanced crossover design to compare the effects of CHOMR or PLA on psychophysiological, kinematic responses and technical actions during 4-a-side SSGs. The study intervention programs lasted the same time of the day during separate training sessions in the in-season to avoid various chronobiological factors. The average temperature was 30 °C, with a relative humidity of 35% of the baseline assessments. Second assessments were recorded that the average temperature was 31 °C with a 35% relative humidity. Before the SSGs sessions, anthropometric characteristics were assessed. Players also completed the Yo-Yo Intermittent Recovery Test level 1 (YYIRTL-1) to balance the groups and equally distribute players among SSGs teams based on maximal oxygen uptake ( 2max). The order of different SSGs (CHOMR or PLA) and solutions (MR or PLA) was determined by randomization (www.randomization.com). Each SSGs was separated at least one week apart to minimize the potential negative impact of physical and psychological fatigue on game performance. Continuous monitoring and recording of the heart rate (HR), rating of perceived exertion (RPE), enjoyment and mental fatigue (MF), kinematic responses, and technical actions were conducted during all SSGs. Mood responses were assessed before and after each SSGs. UEFA A licenced strength and conditioning coaches consistently implemented all SSGs sessions on an artificial soccer pitch with verbal coach encouragement.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tokat, Turkey, 6000
        • Tokat Gaiosmanpasa University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being healthy
  • Male soccer players
  • Willing to maintain the intervention for all sessions

Exclusion Criteria:

  • Being under 14 years old
  • Having a chronic disease
  • Contraindication for carbohydrate mouth-rinsing (CHO-MR)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CHO Mouth Rinse Protocol (CHO-MR)
CHO solution was a maltodextrin-based mixture containing 6.4% maltodextrin (Protein Ocean, Türkiye). An CHOMR was performed prior to SSGs.
CHO solution was a maltodextrin-based mixture containing 6.4% maltodextrin (Protein Ocean, Türkiye). An CHOMR was performed prior to SSGs. The solution was sweetened with non-caloric artificial sweeteners consisting of sucralose. The CHO solution was prepared in an equivalent saccharin base and shaken for 30 seconds in a vortex mixer to ensure distinguishability. Participants swished the solution in their mouth for 10 seconds before SSGs and then emptied it back into the container to be weighed again. To ensure that the solutions were not swallowed, the containers were measured before and after all MRs using a full precision balance (Etekcity, USA) accurate to 1 g/0.04 oz
Experimental: Placebo Protocol
The PLA solution consisted of pure water. A mouth rinse was performed before the SSGs.
The PLA solution consisted of purified water. Both solutions were made indistinguishable by adding 50 mg of non-calorific artificial sweetener and 50 mg of sucralose (Fibrelle, Turkey). A 25 ml bolus of 6.4% maltodextrin solution was used in a pre-weighed plastic container and sucralose water was tested as PLA for each rinse solution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychophysiological Responses-Heart Rate
Time Frame: From baseline to the end of treatment at 2 weeks
Participants used a Polar H10 heart rate (HR) transmitter synchronized with a Polar V800 watch to track the HR throughout the session. Participants' heart rate mean, heart rate peak and heart rate percentage were recorded.
From baseline to the end of treatment at 2 weeks
Psychophysiological Responses-Rating of Perceived Exertion
Time Frame: From baseline to the end of treatment at 2 weeks
Exercise intensity in all test sessions was quantified using the rating of perceived exertion (RPE), which employs a category ratio scale ranging from 6 to 20. This scale has recently been applied in sports psychology to assess effort related to emotions and performance during competitive events.
From baseline to the end of treatment at 2 weeks
Psychophysiological Responses-Enjoyment-Brunel mood of states
Time Frame: From baseline to the end of treatment at 2 weeks
All participants completed the Exercise Enjoyment Scale (EES), which consists of eight items rated on a 1-7 Likert scale. This scale has been validated to measure the enjoyment of exercise in Turkish adolescents and adults. 1 indicates no enjoyment and 7 indicates enjoyment.
From baseline to the end of treatment at 2 weeks
Psychophysiological Reactions-Mood Rating
Time Frame: From baseline to the end of treatment at 2 weeks
A scale consisting of 24 items and six (6) subscales (anger, confusion, depression, fatigue, tension and vitality) was used in all testing sessions. The depression subscale of the scale is an indicator of depressed mood rather than clinical depression. C in all test sessions. The depression subscale of the scale is an indicator of depressed mood rather than clinical depression Participants were asked the question 'How are you feeling right now?' before and after the games and were asked to tick a number between 0 and 4 (0 = not at all, 1 = a little, 2 = moderately, 3 = quite a bit, 4 = extremely).
From baseline to the end of treatment at 2 weeks
Psychophysiological Responses-Mental Fatigue Assessment
Time Frame: From baseline to the end of treatment at 2 weeks
All test sessions were assessed using the MF visual analogue scale (VAS). The VAS is a subjective rating scale that assesses an individual's perception or experience of a particular construct, such as fatigue. To measure MF using the VAS, individuals are typically presented with a horizontal line or scale with one end zero (0) meaning "no fatigue" or "not tired at all" and the other end one hundred (100) meaning "extremely tired" or "very tired". Participants are then asked to place a mark on the line indicating their perceived level of MF.
From baseline to the end of treatment at 2 weeks
Evaluating the total distance (TD)
Time Frame: From baseline to the end of treatment at 2 weeks
During the SSG sessions, total distance (TD)data were recorded using a Global Navigation Satellite System (GNSS) with a frequency of 10 Hertz and a triaxial accelerometer (STATSports, Apex, Northern Ireland) with a frequency of 100 Hertz. All data recorded by the GNSS units were downloaded and processed using STAT Sports Software (Apex version 3.0.02011).
From baseline to the end of treatment at 2 weeks
Assessment of high intensity running distance (HIMD)
Time Frame: From baseline to the end of treatment at 2 weeks
During the SSG sessions, high-intensity running distance (HIMD) data were recorded using a Global Navigation Satellite System (GNSS) with a frequency of 10 Hertz and a triaxial accelerometer (STATSports, Apex, Northern Ireland) with a frequency of 100 Hertz. All data recorded by the GNSS units were downloaded and processed using STAT Sports Software (Apex version 3.0.02011).
From baseline to the end of treatment at 2 weeks
Evaluation of sprint (SD)
Time Frame: From baseline to the end of treatment at 2 weeks
During the SSG sessions, sprint (SD) data were recorded using a Global Navigation Satellite System (GNSS) with a frequency of 10 Hertz and a triaxial accelerometer (STATSports, Apex, Northern Ireland) with a frequency of 100 Hertz. All data recorded by the GNSS units were downloaded and processed using STAT Sport Software (Apex version 3.0.02011).
From baseline to the end of treatment at 2 weeks
Evaluating acceleration (ACC) and deceleration (DCC)
Time Frame: From baseline to the end of treatment at 2 weeks
During the SSG sessions, acceleration (ACC) and deceleration (DCC) data were recorded using a Global Navigation Satellite System (GNSS) with a frequency of 10 Hertz and a triaxial accelerometer (STATSports, Apex, Northern Ireland) with a frequency of 100 Hertz. All data recorded by the GNSS units were downloaded and processed using STAT Sport Software (Apex version 3.0.02011).
From baseline to the end of treatment at 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometric Measurements 1
Time Frame: Baseline
Before breakfast, participants had their weight (kg) measured using a body composition analyser (BC-418MA, Tanita Corp., Tokyo, Japan). This device utilises bioelectrical impedance technology using multiple frequencies (ranging from 1 kHz to 50 kHz) to comprehensively assess body composition parameters.
Baseline
Anthropometric Measurements 2
Time Frame: Baseline
Before breakfast, participants had their height (cm) measured using a body composition analyser (BC-418MA, Tanita Corp., Tokyo, Japan). This device utilises bioelectrical impedance technology using multiple frequencies (ranging from 1 kHz to 50 kHz) to comprehensively assess body composition parameters.
Baseline
Anthropometric Measurements 3
Time Frame: Baseline
Before breakfast, participants had their body mass index (kg/m2) measured using a body composition analyser (BC-418MA, Tanita Corp., Tokyo, Japan). This device utilises bioelectrical impedance technology using multiple frequencies (ranging from 1 kHz to 50 kHz) to comprehensively assess body composition parameters.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erdinc Gorgulu, Doctorate, Tokat Gaziosmanpasa University
  • Study Chair: Yusuf Soylu, Doctorate, Tokat Gaziosmanpasa University
  • Study Chair: Ersan Arslan, Doctorate, Tokat Gaziosmanpasa University
  • Study Chair: Bulent Kilit, Doctorate, Tokat Gaziosmanpasa University
  • Study Chair: Neil D. Clarke, Doctorate, Birmingham City University
  • Study Chair: Haitham Jahrami, Doctorate, Ministry of Health, Manama, Bahrain
  • Study Chair: Achraf Ammar, Doctorate, Johannes Gutenberg University Mainz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2025

Primary Completion (Actual)

April 25, 2025

Study Completion (Actual)

April 26, 2025

Study Registration Dates

First Submitted

May 12, 2025

First Submitted That Met QC Criteria

May 19, 2025

First Posted (Actual)

May 25, 2025

Study Record Updates

Last Update Posted (Actual)

May 25, 2025

Last Update Submitted That Met QC Criteria

May 19, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UGaziosmanpasa-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Fatigue

Clinical Trials on Carbohydrate

Subscribe